Cargando…
DR2 blocker thioridazine: A promising drug for ovarian cancer therapy
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039101/ https://www.ncbi.nlm.nih.gov/pubmed/32194705 http://dx.doi.org/10.3892/ol.2020.11285 |
_version_ | 1783500760834637824 |
---|---|
author | Yong, Min Yu, Tinghe Tian, Si Liu, Shuaibin Xu, Jiao Hu, Jianguo Hu, Lina |
author_facet | Yong, Min Yu, Tinghe Tian, Si Liu, Shuaibin Xu, Jiao Hu, Jianguo Hu, Lina |
author_sort | Yong, Min |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7039101 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-70391012020-03-19 DR2 blocker thioridazine: A promising drug for ovarian cancer therapy Yong, Min Yu, Tinghe Tian, Si Liu, Shuaibin Xu, Jiao Hu, Jianguo Hu, Lina Oncol Lett Corrigendum D.A. Spandidos 2020-03 2020-01-09 /pmc/articles/PMC7039101/ /pubmed/32194705 http://dx.doi.org/10.3892/ol.2020.11285 Text en Copyright: © Yong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited. |
spellingShingle | Corrigendum Yong, Min Yu, Tinghe Tian, Si Liu, Shuaibin Xu, Jiao Hu, Jianguo Hu, Lina DR2 blocker thioridazine: A promising drug for ovarian cancer therapy |
title | DR2 blocker thioridazine: A promising drug for ovarian cancer therapy |
title_full | DR2 blocker thioridazine: A promising drug for ovarian cancer therapy |
title_fullStr | DR2 blocker thioridazine: A promising drug for ovarian cancer therapy |
title_full_unstemmed | DR2 blocker thioridazine: A promising drug for ovarian cancer therapy |
title_short | DR2 blocker thioridazine: A promising drug for ovarian cancer therapy |
title_sort | dr2 blocker thioridazine: a promising drug for ovarian cancer therapy |
topic | Corrigendum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039101/ https://www.ncbi.nlm.nih.gov/pubmed/32194705 http://dx.doi.org/10.3892/ol.2020.11285 |
work_keys_str_mv | AT yongmin dr2blockerthioridazineapromisingdrugforovariancancertherapy AT yutinghe dr2blockerthioridazineapromisingdrugforovariancancertherapy AT tiansi dr2blockerthioridazineapromisingdrugforovariancancertherapy AT liushuaibin dr2blockerthioridazineapromisingdrugforovariancancertherapy AT xujiao dr2blockerthioridazineapromisingdrugforovariancancertherapy AT hujianguo dr2blockerthioridazineapromisingdrugforovariancancertherapy AT hulina dr2blockerthioridazineapromisingdrugforovariancancertherapy |